Clinical Trial Update: Infliximab Therapy for Dolichoectactic Vertebrobasilar Aneurysms [Phase 1, Phase 2]

View source ↗

Summary

Clinical trial evaluating infliximab therapy for dolichoectactic vertebrobasilar aneurysms is currently recruiting in Phase 1/2.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Aneurysm
• Stroke
• Vasculitis
• Vertebrobasilar Dolichoectasia

Drugs mentioned

• Remicade (infliximab)

Snippet

Sponsor: University of California, San Francisco | Conditions: Aneurysm, Stroke | Phase 1, Phase 2 | Status: RECRUITING